Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1

Conditions

Smoldering Multiple Myeloma 1Multiple Myeloma 1Hemangioma, Capillary 1Hemangioma 1

Interventions

Blood Specimen Collection 106Standard of Care 82Exercise 68Radiotherapy 54Radiosurgery 47Magnetic Resonance Spectroscopy 46Specimen Handling 45Practice Guidelines as Topic 44Surveys and Questionnaires 43Interviews as Topic 43Educational Status 42Methods 41Drug Therapy 34Early Intervention, Educational 30Surgical Procedures, Operative 29Palliative Care 25Biopsy 24Control Groups 21venetoclax 17Therapeutics 17Patient Navigation 17Cisplatin 17Proton Therapy 15Magnetic Resonance Imaging 15Behavior Therapy 15Neoadjuvant Therapy 14Cognitive Behavioral Therapy 13Acupuncture Therapy 13Resistance Training 12Nutritional Status 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Recruiting × Adrenergic beta-Antagonists × Clear all
NCT05312255 2025-12-01

Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

Roswell Park Cancer Institute

Phase NA Recruiting
175 enrolled
Plasma cell

Smoldering Multiple Myeloma, Multiple Myeloma

NCT01873131 2023-11-02

A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn

Massachusetts General Hospital

Phase NA Recruiting
126 enrolled

Hemangioma, Hemangioma, Capillary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡